Kaletra Tablet, Film Coated
Product Images NDC 0074-6799

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 0074-6799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Kaletra Tablets And Oral Solution Spl 01

Kaletra Tablets And Oral Solution Spl 01
FDA Label Image

Kaletra Tablets And Oral Solution Spl 02

Kaletra Tablets And Oral Solution Spl 02
FDA Label Image

Kaletra Tablets And Oral Solution Spl 03

Kaletra Tablets And Oral Solution Spl 03
FDA Label Image

Kaletra Tablets And Oral Solution Spl 04

Kaletra Tablets And Oral Solution Spl 04
Kaletra is a medication that consists of Lopinavir and Ritonavir. It is available in tablet form, and each container has 120 tablets. Patients using Kaletra should consult a pharmacist to find out about other medications that should not be taken with it. Kaletra must be stored at temperatures between 20°C - 25°C (68°F - 77°F), and the medicine guide should be provided with each package. Each tablet contains 200mg Lopinavir and 50 mg Ritonavir. The product should be used before the expiration date. The medication is manufactured by Abbv in North Chicago, USA.*
FDA Label Image

Kaletra Tablets And Oral Solution Spl 05

Kaletra Tablets And Oral Solution Spl 05
FDA Label Image

Kaletra Tablets And Oral Solution Spl 06

Kaletra Tablets And Oral Solution Spl 06
FDA Label Image

Kaletra Tablets And Oral Solution Spl 07

Kaletra Tablets And Oral Solution Spl 07
FDA Label Image

Kaletra Tablets And Oral Solution Spl 08

Kaletra Tablets And Oral Solution Spl 08
Kaletra is an oral solution made of Lopinavir and Ritonavir used as a medication for individuals who are infected with HIV (human immunodeficiency virus). The solution, which has an 80mg/20 mg per mL concentration and comes in a 160mL bottle, is stored at a temperature of up to 25°C. Excursions of up to 15-30°C are permitted. Since the packaging contains important information, it is advisable not to cover the expiration date and ALERT box with pharmacy labels. Also, the solution must be dispensed properly.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.